Sex specific changes in placental growth and MAPK following short term maternal dexamethasone exposure in the mouse

Placenta

Volumn 32, Issue 12, 2011, Pages 981-989

  Cuffe, J S M ^a   Dickinson, H ^b   Simmons, D G ^a   Moritz, K M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Fetal programming; Glucocorticoids; Hsd11b2; Vegf

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; AMINO ACID TRANSPORTER; DEXAMETHASONE; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN; UNCLASSIFIED DRUG; VEGFA PROTEIN; GLUCOCORTICOID RECEPTOR; MAPK1 PROTEIN, MOUSE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FETUS; FETUS WEIGHT; GENE EXPRESSION; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PLACENTA DEVELOPMENT; PLACENTA WEIGHT; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; ORGAN SIZE; PATHOLOGY; PLACENTA; PREGNANCY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; DEXAMETHASONE; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; ORGAN SIZE; PLACENTA; PREGNANCY; RECEPTORS, GLUCOCORTICOID; SEX FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859471225     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2011.09.009     Document Type: Article

References (41)

1. Moritz KM, Boon WM, Wintour EM. Glucocorticoid programming of adult disease. Cell Tissue Res 2005;322(1):81-8. (Pubitemid 41677658)
2. Figueroa JP, Rose JC, Massmann GA, Zhang J, Acuna G. Alterations in fetal kidney development and elevations in arterial blood pressure in young adult sheep after clinical doses of antenatal glucocorticoids. Pediatr Res 2005;58(3):510-5. (Pubitemid 41254516)
3. Ortiz LA, Quan A, Zarzar F, Weinberg A, Baum M. Prenatal dexamethasone programs hypertension and renal injury in the rat. Hypertension 2003;41(2):328-34. (Pubitemid 36204910)
4. Woods LL, Weeks DA. Prenatal programming of adult blood pressure: role of maternal corticosteroids. Am J Physiol Regul Integr Comp Physiol 2005;289(4):R955-62. (Pubitemid 41397041)
5. Sugimoto M, Kojima A, Endo H. Role of glucocorticoids in terminal differentiation and tissue specific function. Dev Growth Differ 1976;18(3):319-27. (Pubitemid 8030360)
6. Coan PM, Ferguson-Smith AC, Burton GJ. Developmental dynamics of the definitive mouse placenta assessed by stereology. Biol Reprod 2009;70(6):1806-13. (Pubitemid 38715638)
7. O'Regan D, Kenyon CJ, Seckl JR, Holmes MC. Prenatal dexamethasone 'programmes' hypotension, but stress-induced hypertension in adult offspring. J Endocrinol 2008;196(2):343-52. (Pubitemid 351298520)
8. Dodic M, Hantzis V, Duncan J, Rees S, Koukoulas I, Johnson K, et al. Programming effects of short prenatal exposure to cortisol. FASEB J 2002;16(9):1017-26. (Pubitemid 34753508)
9. Hauser J, Dettling-Artho A, Pilloud S, Maier C, Knapman A, Feldon J, Pryce CR. Effects of prenatal dexamethasone treatment on postnatal physical, endocrine, and social development in the common marmoset monkey. Endocrinology 2007;148(4):1813-22. (Pubitemid 46457098)
10. Dickinson H, Walker DW, Wintour EM, Moritz K. Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse. Am J Physiol Regul Integr Comp Physiol 2007;292(1):R453-61. (Pubitemid 46091602)
11. Salafia CM, Zhang J, Miller RK, Charles AK, Shrout P, Sun W. Placental growth patterns affect birth weight for given placental weight. Birth Defects Res Part A: Clin Mol Teratology 2007;79(4):281-8. (Pubitemid 46980402)
12. Yang K. Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. Rev Reprod 1997;2(3):129-32. (Pubitemid 27416904)
13. Barker DJ, Thornburg KL, Osmond C, Kajantie E, Eriksson JG. The surface area of the placenta and hypertension in the offspring in later life. Int J Dev Biol 2010;54(2-3):525-30.
14. Bell AW, Ehrhardt RA. Regulation of placental nutrient transport and implications for fetal growth. Nutr Res Rev 2002;15(02):211-30. (Pubitemid 35423604)
15. Arroyo JA, Winn VD. Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatology 2008;32(3):172-7. (Pubitemid 351636324)
16. Hewitt DP, Mark PJ, Waddell BJ. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology 2006;147(12):5568-74. (Pubitemid 44833473)
17. Singh RR, Cullen-McEwen LA, Kett MM, Boon WM, Dowling J, Bertram JF, Moritz KM. Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring. J Physiol 2007;579(Pt 2):503-13. (Pubitemid 46351765)
18. Ortiz LA, Quan A, Weinberg A, Baum M. Effect of prenatal dexamethasone on rat renal development. Kidney International 2001;59(5):1663-9. (Pubitemid 32336780)
19. Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci 2008;28(36):9055-65.
20. Moritz K, Koukoulas I, Albiston A, Wintour EM. Angiotensin II infusion to the midgestation ovine fetus: effects on the fetal kidney. Am J Physiol - Regulatory Integr Comp Physiol 2000;279(4):R1290-7.
21. Hartshorn C, Rice JE, Wangh LJ. Developmentally-regulated changes of Xist RNA levels in single preimplantation mouse embryos, as revealed by quantitative real-time PCR. Mol Reprod Dev 2002;61(4):425-36. (Pubitemid 34193588)
22. Simmons DG, Rawn S, Davies A, Hughes M, Cross JC. Spatial and temporal expression of the 23 murine prolactin/placental lactogen-related genes is not associated with their position in the locus. BMC Genomics 2008;9:352.
23. Sugden MC, Langdown ML, Munns MJ, Holness MJ. Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur J Endocrinol 2001;145(4):529-39. (Pubitemid 32927083)
24. Peers A, Hantzis V, Dodic M, Koukoulas I, Gibson A, Baird R, et al. Functional glucocorticoid receptors in the mesonephros of the ovine fetus. Kidney International 2001;59(2):425-33. (Pubitemid 32157907)
25. Moritz KM, Johnson K, Douglas-Denton R, Wintour EM, Dodic M. Maternal glucocorticoid treatment programs alterations in the renin-angiotensin system of the ovine fetal kidney. Endocrinology 2002;143(11):4455-63. (Pubitemid 35239580)
26. van Beek JP, Guan H, Julan L, Yang K. Glucocorticoids stimulate the expression of 11beta-hydroxysteroid dehydrogenase type 2 in cultured human placental trophoblast cells. J Clin Endocrinol Metab 2004;89(11):5614-21. (Pubitemid 39518448)
27. Stark MJ, Wright IM, Clifton VL. Sex-specific alterations in placental 11betahydroxysteroid dehydrogenase 2 activity and early postnatal clinical course following antenatal betamethasone. Am J Physiol Regul Integr Comp Physiol 2009;297(2):R510-4.
28. Mark PJ, Augustus S, Lewis JL, Hewitt DP, Waddell BJ. Changes in the placental glucocorticoid barrier during rat pregnancy: impact on placental corticosterone levels and regulation by progesterone. Biol Reprod 2009;80(6):1209-15.
29. O'Connell BA, Moritz KM, Roberts CT, Walker DW and Dickinson H. The placental response to excess maternal glucocorticoid exposure differs between the male and female conceptus in spiny mice. Biol Reprod. Epub July 27, doi:10.1095/biolreprod.111.093369.
30. Necela BM, Cidlowski JA. Mechanisms of glucocorticoid receptor action in Noninflammatoryandinflammatorycells. ProcAmThoracSoc 2004;1(3):239-46.
31. Hatano N, Mori Y, Oh-hora M, Kosugi A, Fujikawa T, Nakai N, et al. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 2003;8(11):847-56. (Pubitemid 37428014)
32. Bissonauth V, Roy S, Gravel M, Guillemette S, Charron J. Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm during placentogenesis. Development 2006;133(17):3429-40. (Pubitemid 44501845)
33. Coan PM, Ferguson-Smith AC, Burton GJ. Developmental dynamics of the definitive mouse placenta assessed by stereology. Biol Reprod 2004;70(6):1806-13. (Pubitemid 38715638)
34. Bliss SP, Miller A, Navratil AM, Xie J, McDonough SP, Fisher PJ, et al. ERK signaling in the pituitary is required for female but not male fertility. Mol Endocrinol 2009;23(7):1092-101.
35. Hahn T, Barth S, Graf R, Engelmann M, Beslagic D, Reul JMHM, et al. Placental glucose transporter expression is regulated by glucocorticoids. J Clin Endocrinol Metab 1999;84(4):1445-52. (Pubitemid 30644413)
36. Langdown ML, Sugden MC. Enhanced placental GLUT1 and GLUT3 expression in dexamethasone-induced fetal growth retardation. Mol Cell Endocrinol 2001;185(1-2):109-17. (Pubitemid 33103959)
37. Mairesse J, Lesage J, Breton C, Breant B, Hahn T, Darnaudery M, et al. Maternal stress alters endocrine function of the feto-placental unit in rats. Am J Physiol Endocrinol Metab 2007;292(6):E1526-33. (Pubitemid 47084686)
38. Wyrwoll CS, Seckl JR, Holmes MC. Altered placental function of 11{beta}-Hydroxysteroid dehydrogenase 2 knockout mice. Endocrinology 2009;150(3):1287-93.
39. Coan PM, Vaughan OR, Sekita Y, Finn SL, Burton GJ, Constancia M, Fowden AL. Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice. J Physiol 588(Pt 3):527-538.
40. Moritz KM, Cuffe JS, Wilson LB, Dickinson H, Wlodek ME, Simmons DG, Denton KM. Review: sex specific programming: a critical role for the renal renin-angiotensin system. Placenta 2010;31(Suppl):S40-6.
41. Clifton VL. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta 31 Suppl: S33-S39.